The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Association Between Diabetes Mellitus and Post-Discharge Outcomes in Patients Hospitalized with Heart Failure: Findings from the EVEREST Trial
Open accessAbstract
AIMS: We evaluated the impact of diabetes mellitus (DM) and diabetic therapy on outcomes in patients with reduced ejection fraction (EF) after hospitalization for heart failure (HF). DM is prevalent in patients hospitalized with HF, yet inconclusive data exist on the post-discharge outcomes of this patient population. METHODS AND RESULTS: Post-hoc analysis was performed on the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan) study, a randomized trial of patients hospitalized with HF (n = 4133) with median follow-up of 9.9 months. DM status was determined from intake questionnaires and cross-verified by medication history. Univariate relationships were examined using χ(2) test, t-test, and Wilcoxon tests. The two primary outcomes of (i) all-cause mortality (ACM) and (ii) cardiovascular mortality or HF hospitalization (CVM + HFH) were assessed for those with and without DM and by diabetic treatment strategy using log rank tests and multivariable Cox regression models. DM was present in 40% of participants. Patients with DM were more likely to have hypertension, coronary artery disease, and chronic kidney disease. Diabetes was associated with ACM and CVM + HFH (both P < 0.001). Following multivariate risk adjustment, DM was associated with ACM, but this estimate was imprecise [hazard ratio (HR) 1.16; 95% confidence interval (CI) 1.00-1.34] and remained associated with CVM or HFH (HR 1.17; 95% CI 1.04-1.31). Diabetic control strategy did not independently affect outcomes. CONCLUSION: Diabetes is common in patients hospitalized for heart failure with a reduced EF. These patients have a higher post-discharge CVM and higher HF hospitalizations compared with patients with no diabetes. Different diabetic treatment regimens did not appear to influence post-discharge outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in the EVEREST trial in which patients were followed for 9.9 months after a HF hospitalization, T2DM conferred a slightly higher mortality.45”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [45]
In the citing paper
“However, with longer-term follow-up, an association between T2DM and worse outcomes in HF patients becomes evident.”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION
Tarver, T. (2014) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,595
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,246
Fonarow, G. C. (2005) · JAMA · doi:10.1001/jama.293.5.572 · Cited by 1,617
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Roger, V. L. (2004) · JAMA · doi:10.1001/jama.292.3.344 · Cited by 1,616
Home, P. D., Pocock, S. J., Beck-Nielsen, H., Curtis, P. S., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60953-3 · Cited by 1,393
Nieminen, M. S., Brutsaert, D. L., Dickstein, K., Drexler, H., Folláth, F., Harjola, V., Hochadel, M., Michel Komajda, N., Lassus, J. P. E., Lopez-Sendon, J. L., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl193 · Cited by 1,292
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
Nesto, R. W., Bell, D. S. H., Bonow, R. O., Fonseca, V. A., Grundy, S. M., Horton, E. S., Winter, M. L., Porte, D., Semenkovich, C. F., Smith, S. E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 831
Chen, J., Normand, S. T., Wang, Y., & Krumholz, H. M. (2011) · JAMA · doi:10.1001/jama.2011.1474 · Cited by 745
Cited by
Sorted by citations
Items 101–200 of 201
Frișan, A.-C., Mornoş, C., Lazăr, M.-A., Șoșdean, R., Crișan, S., Ionac, I., & Luca, C. T. (2024) · Medicina · doi:10.3390/medicina60020199 · Cited by 10
Positioning Metabolism as a Central Player in the Diabetic Heart
Mereweather, L. J., Aparicio, C. N. M., & Heather, L. C. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.1.92 · Cited by 11
Li, L., Li, G., Chen, H., Feng, Z., Zhang, L., Chen, L., & Fan, L. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s339209 · Cited by 8
Adji, A. S., Widjaja, J. S., & de Liyis, B. G. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00580-5 · Cited by 11
Vaduganathan, M., Dei, A., Mentz, R. J., Greene, S. J., Khan, S. S., Subacius, H. P., Chioncel, O., Maggioni, A. P., Konstam, M. A., Senni, M., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.064 · Cited by 9
Kraiem, N., Polyakov, D. S., Fomin, I. V., Георгиевна, В. Н., Valikulova, F. Y., Вайсберг, А. Р., Badin, Y. V., & Shechrbinina, E. V. (2018) · Kardiologiia · doi:10.18087/cardio.2439 · Cited by 8
Witte, K. K., Wachter, R., Senni, M., Bělohlávek, J., Straburzyńska‐Migaj, E., Fonseca, C., Lonn, E., Noè, A., Schwende, H., Butylin, D., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14166 · Cited by 7
Formiga, F., Chivite, D., Montero, A., Petit, I., Moreno‐González, R., Franco, J., & Corbella, X. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13215 · Cited by 8
Pepin, M. E., Gong, X., Schulze, A., & Backs, J. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00343-y · Cited by 8
Zhang, K., Han, Y., Yu, G., Gu, F. M., Cai, T., Gu, Z. X., Yu, Z. J., Gao, M., Gao, Y. F., Hu, R. M., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1354614 · Cited by 8
Mechanisms and Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury in Diabetic States
Xue, J., Zhuang, J., Wang, X., Meng, T., Wu, J. Q., Zhang, X., & Zhang, G. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00272 · Cited by 10
Jin, B.-Y., Song, J., Kim, J. Y., Park, J.-H., Kim, S. J., Cho, H., Moon, S., Kim, D.-H., & Ahn, S. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154171 · Cited by 7
Acute heart failure in the emergency department: a follow-up study
Fabbri, A., Marchesini, G., Carbone, G., Cosentini, R., Ferrari, A., Chiesa, M., BERTINI, A., & Rea, F. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1336-z · Cited by 7
Is the Blood Pressure Paradox Observed in All Heart Failure Patients?
Cunha, F. M., Lourenço, P., Reina‐Couto, M., Tavares, P., Silva, S. C. P. D., Guimarães, J. T., & Bettencourt, P. (2013) · BioMed Research International · doi:10.1155/2013/350289 · Cited by 7
Cardiovascular risk in type 2 diabetes patients
Ostroumova, O. D., Васильевна, Г. И., & Михайловна, Ф. В. (2018) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2018-4-81-94 · Cited by 9
Prognostic impact of diabetes in chronic and acute heart failure
Ghio, S., Mercurio, V., Attanasio, A. F., Asile, G., Tocchetti, C. G., & Paolillo, S. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10193-8 · Cited by 6
Bashier, A. M., Farghaly, M., Ali, J. A., Alhadari, A. K., Ajaz, Y., Warrier, V. K., Abdelgadir, E., Farooqi, M. H., Qamar, S., Alsayed, M., et al. (2023) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000530467 · Cited by 6
Effect of Cardiac Resynchronization Therapy in Patients with Diabetes Randomized in EchoCRT
Nägele, M. P., Steffel, J., Robertson, M., Singh, J. P., Flammer, A. J., Bax, J. J., BORER, J. S., Dickstein, K., Ford, I., Gorcsan, J., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.655 · Cited by 6
Practical Considerations and Opportunities for SGLT2 Inhibitor Prescription in Heart Failure
Faulkenberg, K. D., Williams, J. B., Isaacs, D. M., & West, L. M. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00825-x · Cited by 6
Obaid, N., Elhadidy, S., Badry, M. E., & Khaled, H. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.655 · Cited by 5
Povar-Echeverría, M., Méndez‐Bailón, M., Martín‐Sánchez, F. J., Montero-Pérez-Barquero, M., Trullàs, J. C., & Miró, Ò. (2023) · Revista Clínica Española · doi:10.1016/j.rce.2023.07.007 · Cited by 6
Schupp, T., Abumayyaleh, M., Weidner, K., Lau, F., Reinhardt, M., Abel, N., Schmitt, A., Forner, J., Ayasse, N., Bertsch, T., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030742 · Cited by 5
Roles of cMyBP-C phosphorylation on cardiac contractile dysfunction in db/db mice
Desai, D. A., Baby, A., Ananthamohan, K., Green, L. C., Arif, M., Duncan, B. C., Kumar, M., Singh, R. R., Koch, S. E., Natesan, S., et al. (2024) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2024.100075 · Cited by 5
Risk factors for acute decompensated heart failure in type 2 diabetes patients
Koziolova, N. A., Veklich, A. S., & Karavaev, P. G. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4-3717 · Cited by 5
Lin, S. N., Phang, K. K., Toh, S. H., Chee, K. H., & Huri, H. Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00448 · Cited by 5
Heart Failure in Diabetes Mellitus: An Updated Review
Sohrabi, C., Saberwal, B., Lim, W. Y., Tousoulis, D., Ahsan, S., & Παπαγεωργίου, Ν. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201118091659 · Cited by 5
Hermans, M. P., Bouénizabila, E., Amoussou-Guénou, D., Ahn, S. A., & Rousseau, M. F. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0226-z · Cited by 4
Salvador, D., Bano, A., Wehrli, F., González-Jaramillo, V., Laimer, M. W., Hunziker, L., & Muka, T. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01903-7 · Cited by 4
Carrasco-Sánchez, F. J., Iglesias, J. R., & Amorós, J. G. (2014) · Medicina Clínica · doi:10.1016/s0025-7753(14)70085-5 · Cited by 4
Zhang, K., Zhang, T., Lv, Q., Han, Y., Cai, T., Gu, F. M., Gu, Z. X., Zhao, J. Y., liang, J. Y., Gao, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63603-w · Cited by 4
Butala, N. M., Johnson, B. K., Dziura, J. D., Reynolds, J. S., Bozzo, J., Balcezak, T. J., Inzucchi, S. E., & Horwitz, L. I. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2321 · Cited by 4
Acute Heart Failure Comorbidome: The Impact of Everything Else
Meireles, M., Golçalves, J., & Neves, J. (2020) · Acta Médica Portuguesa · doi:10.20344/amp.11051 · Cited by 4
A roadmap to inpatient heart failure management
Vaduganathan, M., & Gheorghiade, M. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.08.011 · Cited by 4
Юрьева, М. Ю., & Dvoryashina, I. V. (2017) · Kardiologiia · doi:10.18087/cardio.2403 · Cited by 4
Kanbakan, A. (2024) · doi:10.5152/2314 · Cited by 3
Steinke, P., Schupp, T., Kuhn, L., Abumayyaleh, M., Ayoub, M., Mashayekhi, K., Bertsch, T., Ayasse, N., Jannesari, M., Siegel, F. P., et al. (2024) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2024.12.001 · Cited by 3
Cidade-Rodrigues, C., Cunha, F. M., Elias, C., Carreira, M., Barroso, I., Bettencourt, P., & Lourenço, P. (2022) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000197 · Cited by 3
Romero, A., Saldarriaga, C., Ramos, C. E., Quesada, D., Chazzin, G., Fernández, F. N. G., Pow-Chon-Long, F., Alarco, W., Hurtado, P. E., Magaña, J. A., et al. (2023) · Archivos de cardiología de México · doi:10.24875/acm.23000059 · Cited by 3
Yang, Y., Huang, Z., Wu, B., Lü, J., Xiu, J., Tu, J., Chen, S., Pan, Y., Bao, K., Wang, J., et al. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03525-0 · Cited by 3
Classification of Patients Hospitalized for Heart Failure
Vaduganathan, M., Marti, C. N., Georgiopoulou, V. V., Kalogeropoulos, A. P., & Butler, J. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.04.002 · Cited by 3
Carrasco-Sánchez, F. J., Páez‐Rubio, M. I., Arévalo‐Lorido, J. C., Carretero‐Gómez, J., Martel, A. C., Epelde, F., Álvarez-Rocha, P., Salamanca-Bautista, M. P., Cepeda-Rodrigo, J. M., & Montero-Pérez-Barquero, M. (2021) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2021.04.010 · Cited by 3
Hypertension Treatment in Diabetes
Bensimhon, H. F., & Cavender, M. A. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.06.008 · Cited by 3
Prevalence and short-term prognosis of heart failure: An in hospital prevalence study
Mishra, T. K., Das, B., & Routray, S. (2018) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2018.04.003 · Cited by 2
Diabetes as a Predictor of In-Hospital and One-Year Outcomes After Decompensated Heart Failure
Fairman, E. B., Delfino, F. A., Mauro, V. M., Charask, A. A., Costa, Y. C., Raffaeli, A., Rojo, L., Rowain, V. R., Cáceres, L., & Barrero, C. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100579 · Cited by 2
Chunawala, Z. S., Fudim, M., Arora, S., Qamar, A., Vaduganathan, M., Mentz, R. J., Pandey, A., & Caughey, M. C. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.07.035 · Cited by 2
Pivovarova, A. I., Соболева, Г. Н., Стукалова, О. В., Козлова, Е. В., Лопухова, В. В., Ternovoy, S. K., & IuA, K. (2022) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin20221704176 · Cited by 2
Povar-Echeverría, M., Méndez‐Bailón, M., Martín‐Sánchez, F. J., Montero-Pérez-Barquero, M., Trullàs, J. C., & Miró, Ò. (2023) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2023.09.007 · Cited by 2
Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
Cunha, F. M., Pereira, J. C., Marques, P. S., Moreira, H., Rodrigues, P., Pinto, M. J., Lourenço, P., & Bettencourt, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1426705 · Cited by 2
Alkagiet, S., & Τζιόμαλος, Κ. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i5.150 · Cited by 2
Carrasco-Sánchez, F. J., Páez‐Rubio, M. I., Arévalo‐Lorido, J. C., Carretero‐Gómez, J., Martel, A. C., Epelde, F., Álvarez-Rocha, P., Salamanca-Bautista, M. P., Cepeda-Rodrigo, J. M., & Montero-Pérez-Barquero, M. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2021.04.006 · Cited by 2
Mitrea, A., Vladu, I. M., Rosu, M. M., Clenciu, D., Moța, E., & Moța, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002510 · Cited by 2
Risk stratification in patients hospitalized for acute heart failure in Asian population
Chang, H., Cheng, H., Huang, W., Lee, C., Guo, C., Yu, W., Chen, C., & Sung, S. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000340 · Cited by 2
Cerdà, P., Franco, J., Chivite, D., & Formiga, F. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.03.003 · Cited by 1
Goyal, A., Tariq, M. D., Khan, A. M., Hurjkaliani, S., Ahsan, A., Saeed, H., Trivedi, R., Mahalwar, G., Daoud, M., & Belur, A. D. (2025) · Heart Rhythm O2 · doi:10.1016/j.hroo.2025.02.020 · Cited by 1
The EJHF Last Editor’s Legacy: How can a High Impact Factor be Built?
Metra, M. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12032 · Cited by 1
EMPA-REG OUTCOME and reduction of the risk of heart failure in patients with diabetes
Karásek, D. (2016) · Interní medicína pro praxi · doi:10.36290/int.2016.038 · Cited by 1
Bidirectional impact of two chronic diseases: heart failure and diabetes mellitus
Soto, J. T., & Ventura, H. O. (2016) · Medwave · doi:10.5867/medwave.2016.6823 · Cited by 1
New heart failure pharmacotherapy in clinical trials: a hope in progress
Selim, A. M. A., Zolty, R., & Chatzizisis, Y. S. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1358614 · Cited by 1
Mai, Z., Li, H., Chen, G., Chen, E., Liu, L., Lun, Z., Lai, W., Zhou, C., Yu, S., Liu, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-231920/v1 · Cited by 1
Assessing Risks of Glucose Lowering Therapy in Heart Failure: Should We Rely on Post-hoc Analyses?
Hsu, J. J., & Fonarow, G. C. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0486-5
Ortega, I. G. (2015) · doi:10.14201/gredos.129680
Heart failure and diabetes: lessons from outcome studies
Vitale, C., & Kaski, J. C. (2016) · Medicographia
Mishra, T. K., & Mishra, S. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/613
Seguridad de los fármacos antidiabéticos en pacientes con insuficiencia cardiaca
Carrasco-Sánchez, F. J., Ostos-Ruiz, A. I., & Soto-Martín, M. (2017) · Revista Clínica Española · doi:10.1016/j.rce.2017.07.007
Safety of diabetes drugs in patients with heart failure
Carrasco-Sánchez, F. J., Ostos-Ruiz, A. I., & Soto-Martín, M. (2017) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2017.07.002
Vijayakumar, S., Vaduganathan, M., & Butler, J. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1423962 · Cited by 1
Sharma, D. S. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i8.46
Mechanisms and treatment of heart failure in diabetes
Timmons, J. G., & Fisher, M. (2018) · Practical Diabetes · doi:10.1002/pdi.2177
Diabetes mellitus and heart failure: insights from a toxic relationship
Hundertmark, M., & Wicks, E. C. (2018) · Practical Diabetes · doi:10.1002/pdi.2176
Khazova, E. V., Bulashova, O. V., OSLOPOV, V. N., & MALKOVA, M. I. (2018) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2018.11(5).124-129
Mesa 2: Insuficiencia cardíaca y diabetes mellitus tipo 2
Méndez, J., Martín, C. G., Remón, J., Houssay, S., Forte, E. H., Manfredo, S., Roselli, M., Ré, M., Hernández, D., Margossian, M., et al. (2020) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v54i2sup.252
Li, L., Li, G., Chen, H., Feng, Z., Chen, Y., Zhang, L., Li, S., Chen, L., & Fan, L. (2020) · Research Square · doi:10.21203/rs.3.rs-130645/v1
Raharinavalona, S. A., Raherison, R. E., Razanamparany, T., Ralamboson, S. A., Andrianasolo, R. L., & Rakotomalala, A. D. P. (2022) · Research Square · doi:10.21203/rs.3.rs-1941880/v1
Heart Failure and Cardiac Dysfunction in Diabetes
Afari, M. E., & Givertz, M. M. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_27
Diabetes, prediabetes, and heart failure
Rosano, G. M. C., Butler, J., Seferovic, P. M., Seferović, J. P., & Cosentino, F. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780198891628.003.0073
Adherence to the therapy of patients with Heart Failure and Diabetes Mellitus: A Systematic Review
Philippou, K., Kyriakou, M., Middleton, N., Charalambous, A., Raftopoulos, V., Constantinou, M., & Lambrinou, E. (2023) · Medical Research Archives · doi:10.18103/mra.v11i12.4585
迪达尔, ·. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141161
Sıvı ve Elektrolit Bozuklukları
DEMIRTAKAN, T. (2024) · doi:10.5152/2311
Akdeniz, Y. S. (2024) · doi:10.5152/2313
Erişkin İleri Kardiyak Yaşam Desteği
BIBEROĞLU, S. (2024) · doi:10.5152/2303
Aman, G. (2024) · doi:10.5152/2307
ÖZKAN, S. (2024) · doi:10.5152/2305
Batıkan, E. (2024) · doi:10.5152/2315
Non-İnvaziv ve İnvaziv Mekanik Ventilasyon
İPEKCI, A. (2024) · doi:10.5152/2302
Pediatrik İleri Kardiyak Yaşam Desteği
ÖZKAN, S. (2024) · doi:10.5152/2304
Akdeniz, Y. S., & Çirkin, Y. (2024) · doi:10.5152/2310
Orhan, Ç. (2024) · doi:10.5152/2306
Kırmızı Alan: Acilde Kritik Vakalar I
Ikızcelı, İ., Özkan, S., İpekci, A., Kanbakan, A., Orhan, Ç., Batıkan, E., Çakmak, F., Aman, G., Yılmaz, N., Biberoğlu, S., et al. (2024) · doi:10.5152/2300
İPEKCI, A. (2024) · doi:10.5152/2312
Akdeniz, Y. S. (2024) · doi:10.5152/2316
Kaur, P., George, P. P., Xian, S. N. H., Yip, W. F., Seng, E. C. S., Tay, R. Y., Tan, J., Chu, J., Low, Z. J., Tey, L. H., et al. (2024) · Journal of Palliative Medicine · doi:10.1089/jpm.2024.0067
Raharinavalona, S. A., Miandrisoa, R. M., Randrianomanana, T. V., Andrianasolo, R. L., & Rakotomalala, A. D. P. (2024) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s477852
Huang, W., Kimmel, S. E., Ahmed, M. M., Smith, S. M., Lee, Y. A., Yang, L., Hernandez, I., Bian, J., & Guo, J. S. (2025) · JMIR Formative Research · doi:10.2196/71595
Schechter, M., Cohen, C. M., Yanuv, I., Rozenberg, A., Chodick, G., Bodegård, J., Leiter, L. A., Verma, S., Lambers-Heerspink, H. J., Karasik, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056266
Salvador, D., Bano, A., Wehrli, F., González-Jaramillo, V., Laimer, M., Hunziker, L., & Muka, T. (2024) · Figshare · doi:10.6084/m9.figshare.26603803
The Role of the Heart in Cardiovascular-Kidney-Metabolic Syndrome
Stanciu, S., Pucerea, S., & Florescu, A.-G. (2025) · Springer eBooks · doi:10.1007/978-3-032-11445-7_13
Li, X.-J., Wang, P. P., Fan, Y.-Q., & Han, Q. H. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261429030
Role of Epac2 in high glucose-mediated cardiac calcium mishandling.
Hayek, M. S. E. (2020) · theses.fr (ABES) · doi:10.70675/c2d7d63fzf026z4bbbz9358z403c1386e2c7
Karami, M., Nazari, F., Hashemi, N., & Dehkordi, L. M. (2026) · Health Science Reports · doi:10.1002/hsr2.72302 · Cited by 2
Chen, J., Liang, Y., Wu, J., Li, H., Wang, X., Qin, F., & Meng, Z. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2026.101977
Metadata
- Authors
- Sarma, S., Mentz, R. J., Kwasny, M. J., Fought, A. J., Huffman, M., Subacius, H., Nodari, S., Konstam, M., Swedberg, K., Maggioni, A. P., Zannad, F., Bonow, R. O., & Gheorghiade, M.
- Affiliations
- Northwestern University (US)
- Duke University (US)
- University of Brescia (IT)
- Tufts University (US)
- University of Gothenburg (SE)
- Associazione Nazionale Medici Cardiologi Ospedalieri (IT)
- Department of Cardiology, Nancy University , Nancy ,
- Corresponding author
- Gheorghiade, Mihai
- ORCID
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 194-202
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- PMC
- PMC4176083
- OpenAlex
- W2085741095
- Cited by
- 202
- References
- 33
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 27 · 2023: 11 · 2022: 11 · 2021: 16 · 2020: 23 · 2019: 8 · 2018: 29 · 2017: 17 · 2016: 18 · 2015: 15 · 2014: 11 · 2013: 8
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Heart Failure (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, public-domain)
- Funders
- Northwestern University
- Feinberg School of Medicine
- National Institute of General Medical Sciences (T32GM086330)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes mellitus, heart failure, reduced ejection fraction, post-discharge outcomes, all-cause mortality, cardiovascular mortality, heart failure hospitalization, EVEREST trial, tolvaptan, vasopressin receptor antagonism, comorbidities
- MeSH terms
- Tolvaptan, Adult, Aged, Aged, 80 and over, Benzazepines, Cause of Death, Combined Modality Therapy, Cross-Sectional Studies, Diet, Diabetic, Female, Follow-Up Studies, Hospitalization, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Discharge, Comorbidity, Proportional Hazards Models, Treatment Outcome, Disease Progression, Diabetes Complications, Heart Failure, Systolic, Antidiuretic Hormone Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review